Advanced search
Publication Cover
Clinical Toxicology Volume 55, 2017 - Issue 8
Submit an article Journal homepage
355
Views
13
CrossRef citations to date
0
Altmetric
Short Communication

Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus

Maren Hermanns-ClausenPoisons Information Centre, Centre for Pediatrics, Medical Center – University of Freiburg, Germany; Correspondence[email protected]
View further author information
,
Verena AngererDepartment of Forensic Toxicology, Institute of Forensic Medicine, Medical Center – University of Freiburg, GermanyView further author information
,
Josephine KithinjiPoisons Information Centre, Centre for Pediatrics, Medical Center – University of Freiburg, Germany; View further author information
,
Christina GrumannDepartment of Forensic Toxicology, Institute of Forensic Medicine, Medical Center – University of Freiburg, GermanyView further author information
&
Volker AuwärterDepartment of Forensic Toxicology, Institute of Forensic Medicine, Medical Center – University of Freiburg, GermanyView further author information
Pages 922-924 | Received 29 Jan 2017, Accepted 07 Apr 2017, Published online: 04 May 2017

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Valérie Proulx & Benoit Tousignant. (2021) Drugs of abuse and ocular effects. Clinical and Experimental Optometry 104:5, pages 567-578.
Read now

Articles from other publishers (12)

Amanda L A Mohr, Barry K Logan, Melissa F Fogarty, Alex J Krotulski, Donna M Papsun, Sherri L Kacinko, Marilyn A Huestis & Jeri D Ropero-Miller. (2022) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review. Journal of Analytical Toxicology 46:6, pages e116-e185.
Crossref
Tanja M. Gampfer, Lea Wagmann, Benedikt Pulver, Folker Westphal, Veit Flockerzi & Markus R. Meyer. (2022) A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay – Exemplified for nine compounds. Toxicology 476, pages 153258.
Crossref
Adam J. Potts, Simon H.L. Thomas & Simon L. Hill. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 279 300 .
Deborah Rudin, Matthias E. Liechti & Dino Luethi. (2021) Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Experimental Neurology 343, pages 113778.
Crossref
Katarzyna Kamińska, Paweł Świt & Kamilla Malek. (2020) 2-(4-Iodo-2,5-dimethoxyphenyl)- N -[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review . Journal of Analytical Toxicology 44:9, pages 947-956.
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Jolanta B. Zawilska, Monika Kacela & Piotr Adamowicz. (2020) NBOMes–Highly Potent and Toxic Alternatives of LSD. Frontiers in Neuroscience 14.
Crossref
Nicole S. Jones & Jeffrey H. Comparin. (2020) Interpol review of controlled substances 2016–2019. Forensic Science International: Synergy 2, pages 608-669.
Crossref
Laura Mercolini. 2019. Critical Issues in Alcohol and Drugs of Abuse Testing. Critical Issues in Alcohol and Drugs of Abuse Testing 247 258 .
Kelly Francisco da Cunha, Marcos Nogueira Eberlin, Marilyn A. Huestis & José Luiz Costa. (2018) NBOMe instability in whole blood. Forensic Toxicology 37:1, pages 82-89.
Crossref
Laura Hondebrink, Anne Zwartsen & Remco H.S. Westerink. (2018) Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?. Pharmacology & Therapeutics 182, pages 193-224.
Crossref
Mario Thevis, Tiia Kuuranne & Hans Geyer. (2018) Annual banned-substance review: Analytical approaches in human sports drug testing. Drug Testing and Analysis 10:1, pages 9-27.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.